Are booster immunisations needed for lifelong hepatitis B immunity?
about
Hepatitis B and the need for a booster doseHepatitis B Virus infection in HIV-positive population in Brazil: results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil.Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescenceA cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines.Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of lifeImmune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccineImmunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.Preventing infective complications in inflammatory bowel disease.Hepatitis B vaccine by intradermal route in non responder patients: an update.Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US citiesCD3Z genetic polymorphism in immune response to hepatitis B vaccination in two independent Chinese populationsThe effects of different dosage levels of hepatitis B vaccine as booster on anti-HBs-negative children 5-15 y after primary immunization; China, 2009-2010.Prevention of hepatitis B infections: vaccination and its limitations.Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).Recent updates in hepatitis vaccination and the prevention of hepatocellular carcinoma.Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.Too much of a good thing? When to stop catch-up vaccinationEpidemiology and prophylaxis of viral hepatitis: a global perspective.Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.Progress in the prevention and control of viral hepatitis type B: closing remarks.Four-year follow up of hepatitis C patients vaccinated against hepatitis B virusDurability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan.Let It "B"? The role of Hepatitis B universal vaccination among italian problematic drug users.Hepatitis B serologic survey and review of immunization records of children, adolescents and adults in Fiji, 2008-2009.Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 yearsVaccines for neonatal viral infections: hepatitis B vaccine.Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adultsThe Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation.An "immune barrier" is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother.24 year outcomes of hepatitis B vaccination in Hangzhou, China.Hepatitis B infection in microbiology laboratory workers: prevalence, vaccination, and immunity status.Should hepatitis B vaccine be used for infants?New hepatitis B vaccine formulated with an improved adjuvant system.UK vaccination schedule: persistence of immunity to hepatitis B in children vaccinated after perinatal exposureImmunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in GermanyHepatitis B vaccination in travelers.Immune response to hepatitis B virus vaccine in celiac subjects at diagnosis.
P2860
Q28239937-6A9B576D-69CD-4F39-B1EC-618D4A565C94Q33234909-76F78598-4E16-4224-AB9D-D0AD8EC68ED9Q33294724-906A4C52-8FE6-4BB2-A2AC-5074F194F725Q33355656-10CF2F86-5EE8-408A-8184-7DF98036F62DQ33524566-AE31163A-C096-4F99-A2E1-BA838C6A4E5AQ33577990-CA356BB2-32DF-48FB-89A9-2EB185A16B03Q33723540-95109A2B-92BA-44CC-AB49-2C8A8CD9935AQ34008766-69C16A1B-004D-4022-8C37-1814E63132AAQ34036643-087E9240-BF51-4771-B5C9-22EE69AD32D7Q34067472-EBB443CA-1A8E-4C9A-9995-D7A5D0877C76Q34247198-0F58DAB3-9A8B-4489-9F48-6952903E26B6Q34290738-DF1A4659-5B29-4475-8EFB-C1EE7CFFFF7BQ34402540-76F44836-2AC7-435E-B0EC-32700273D199Q34464990-41A5D3BA-019C-4F86-9DF0-D86F241CB6B1Q34483036-B715DB4B-6ABA-46B0-A9AA-3F19C792CD55Q34581747-0E1BDF32-A52C-4FCA-BC1E-011329F217D2Q34585496-70A19D47-4D91-47F8-911A-EF1A88DCD165Q34631380-8E4AB45B-EDCE-4670-967F-A1A2818688ECQ34737096-C535C14C-DD0C-4374-9948-21F64C846D05Q34737132-46D937DF-1323-4B56-8F32-96DD18C305DBQ35011088-242FB8CF-17B6-4D2A-B0EA-22A438EB0F08Q35055166-F2E938C1-3B0F-4D1B-9B61-6208C7F766B2Q35108823-756AE259-4903-4963-9F48-96D9486A7480Q35539786-39B11962-3BF3-4DCA-BE31-5ECDFFECF8B9Q35555723-91E1D656-3B7B-4B54-81F2-81CBED9F0902Q35577825-705DE1F2-42AA-4247-8FB1-1E42F1283CB5Q35843597-19164D37-60DF-4DD8-9973-56C4393C514BQ35878625-32D5E4AC-79AB-48AC-9622-76DE91F4F4E4Q35944621-C0E2FA5B-23A8-4152-AFBA-745C1860811BQ36255826-B36FC4A8-481A-4B16-AC23-D6F7071434E2Q36256369-414F21D4-3C87-4EEB-9FA9-E41CD76E9FC0Q36486399-0A0C8760-BC1A-4EFE-94F4-57A30BBA8ACCQ36728785-DB82D4E8-FAF8-4417-9ED6-A481153CF7B5Q36780117-DA021A74-E686-422E-985A-A5CF50D0617FQ36876700-740DEF2C-7A4E-447A-9A04-DABF32D03DA9Q36978399-A1894F5E-C69C-4363-BF5E-6511765CD6FEQ37123438-B9E81828-F151-4575-9E20-F33E1EFAD34DQ37135095-BECB8EBA-BEE4-4C39-812B-02C2CDBB782EQ37194803-871B586B-ED5F-46C5-A882-B1156C8E28A7Q37263069-4CB2F3F0-F302-42A8-AC25-02FAD956D227
P2860
Are booster immunisations needed for lifelong hepatitis B immunity?
description
article publié dans la revue scientifique The Lancet
@fr
im Februar 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Lancet
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2000
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
Are booster immunisations needed for lifelong hepatitis B immunity?
@en
Are booster immunisations needed for lifelong hepatitis B immunity?
@nl
type
label
Are booster immunisations needed for lifelong hepatitis B immunity?
@en
Are booster immunisations needed for lifelong hepatitis B immunity?
@nl
prefLabel
Are booster immunisations needed for lifelong hepatitis B immunity?
@en
Are booster immunisations needed for lifelong hepatitis B immunity?
@nl
P1433
P1476
Are booster immunisations needed for lifelong hepatitis B immunity?
@en
P304
P356
10.1016/S0140-6736(99)07239-6
P407
P577
2000-02-01T00:00:00Z